Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

OBJECTIVE: To compare patient reported measures of function, health related quality of life (QoL), and satisfaction with medication among patients with rheumatoid arthritis (RA) treated with methotrexate (MTX), etanercept, or both for up to 1 year. METHODS: In a 52 week, double blind, clinical trial...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: van der Heijde, D, Klareskog, L, Singh, A, Tornero, J, Melo‐Gomes, J, Codreanu, C, Pedersen, R, Freundlich, B, Fatenejad, S
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2006
Assuntos:
Extended Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798055/
https://ncbi.nlm.nih.gov/pubmed/16079172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.035709
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares